Angi Inc.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
ANGI$6.60-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (In thousands) | ||
| Cash flows from operating activities: | ||
| Net (loss) earnings | $(8,978) | $15,106 |
| Adjustments to reconcile net (loss) earnings to net cash (used in) provided by operating activities: | ||
| Depreciation | 14,694 | 9,948 |
| Provision for credit losses | 10,338 | 11,314 |
| Stock-based compensation expense | 2,752 | (2,287) |
| Non-cash lease expense (including impairment of right-of-use assets) | 1,921 | 1,786 |
| Deferred income taxes | 482 | 2,717 |
| Gain on extinguishment of debt | (2,739) | — |
| Other adjustments, net | 444 | (451) |
| Changes in assets and liabilities: | ||
| Accounts receivable | (14,790) | (14,773) |
| Other assets | 851 | 2,469 |
| Accounts payable and other liabilities | (16,285) | (20,390) |
| Income taxes payable and receivable | (2,047) | 1,417 |
| Operating lease liabilities | (3,461) | (3,270) |
| Deferred revenue | (1,085) | (6,699) |
| Net cash used in operating activities | (17,903) | (3,113) |
| Cash flows from investing activities: | ||
| Capital expenditures | (15,725) | (12,574) |
| Proceeds from sales of fixed assets | 32 | 75 |
| Net cash used in investing activities | (15,693) | (12,499) |
| Cash flows from financing activities: | ||
| Repurchases of debt | (23,744) | — |
| Withholding taxes paid on behalf of employees on net settled stock-based awards | (1,798) | (4,542) |
| Purchases of treasury stock | — | (9,801) |
| Net cash used in financing activities | (25,542) | (14,343) |
| Total cash used | (59,138) | (29,955) |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 17 | (26) |
| Net decrease in cash and cash equivalents and restricted cash | (59,121) | (29,981) |
| Cash and cash equivalents and restricted cash at beginning of period | 303,701 | 416,545 |
| Cash and cash equivalents and restricted cash at end of period | $244,580 | $386,564 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.